Bajaj Healthcare has approved the sale of its operational business unit situated at Plot No. N-178, MIDC, Tarapur Industrial Area, Boisar, to M/s Orchem Products for a consideration of up to ₹4.05 Cr. The transaction is expected to be completed on or before October 31, 2026, subject to the execution of definitive transaction documents. The Board of Directors approved the sale via a circular resolution passed on June 23, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Tarapur unit contributed ₹3.31 Cr to the company's revenue, representing 0.54% of the total, and held a net worth of ₹3.97 Cr, or 0.74%, during the last financial year. The buyer, M/s Orchem Products, is not part of the promoter, promoter group, or group companies, confirming that the transaction does not fall within the purview of Related Party Transactions. Furthermore, the sale does not qualify as a slump sale or an undertaking under the Companies Act, 2013.

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of Bajaj Healthcare Limited will remain closed for all Directors, Designated Persons, and their immediate relatives. The closure takes effect immediately and will last until 48 hours after the formal execution and signing of the definitive agreements.

Key Financials of the Unit

Transaction Details

Anil Champalal Jain, Managing Director and member of the promoter group of Bajaj Healthcare , acquired 1,00,000 equity shares through an open market transaction on June 12, 2026. The acquisition increases the promoter group's stake in the pharmaceutical company, reflecting a direct addition to their shareholding.

Transaction Details

The disclosure was submitted to the exchanges under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The key details of the transaction are outlined below:

Shareholding Pattern

Following the acquisition, the total shareholding of the acquirer along with Persons Acting in Concert (PAC) has increased. The table below details the holding before and after the transaction:

The total paid-up equity share capital of Bajaj Healthcare Limited stands at 3,36,62,661 equity shares of ₹5 each, aggregating to ₹16,83,13,305. The shares of the company are listed on BSE Limited and National Stock Exchange of India Limited.